Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Hepatitis

  Free Subscription


10.10.2022

1 Am J Gastroenterol
1 Am J Med
1 Arch Virol
1 Hepatology
1 J Infect Dis
1 J Med Virol
5 J Viral Hepat


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Am J Gastroenterol

  1. VELOZ MFG, Han K, Oakes K, Robertson D, et al
    Results of a model of delivering hepatitis C care in a homeless metropolitan population in England.
    Am J Gastroenterol. 2022 Sep 30. pii: 00000434-990000000-00534.
    PubMed         Abstract available


    Am J Med

  2. TERMEIE O, Fiedler L, Martinez L, Foster J, et al
    Alarming Trends: Mortality from Alcoholic Cirrhosis in the United States.
    Am J Med. 2022;135:1263-1266.
    PubMed         Abstract available


    Arch Virol

  3. HUAREZ B, Hernandez-Vasquez A, Azanedo D, Vargas-Fernandez R, et al
    Prevalence of hepatitis C virus infection in patients with end-stage renal disease in Latin America and the Caribbean: a systematic review and meta-analysis.
    Arch Virol. 2022 Oct 5. pii: 10.1007/s00705-022-05604.
    PubMed         Abstract available


    Hepatology

  4. BALOG S, Fujiwara R, Pan SQ, El-Baradie KB, et al
    Emergence of highly profibrotic and proinflammatory Lrat(+) Fbln2(+) hepatic stellate cell subpopulation in alcoholic hepatitis.
    Hepatology. 2022 Oct 1. doi: 10.1002/hep.32793.
    PubMed         Abstract available


    J Infect Dis

  5. ARANDAY-CORTES E, McClure CP, Davis C, Irving WL, et al
    Real-World Outcomes of DAA Treatment and Retreatment in UK-based Patients Infected with HCV Genotypes/Subtypes Endemic in Africa.
    J Infect Dis. 2021 Mar 1. pii: 6154708. doi: 10.1093.
    PubMed         Abstract available


    J Med Virol

  6. ZHANG F, Yang Z, Dai C, He Q, et al
    Efficacy of an accelerated vaccination schedule against hepatitis E virus infection in pregnant rabbits.
    J Med Virol. 2022 Oct 6. doi: 10.1002/jmv.28193.
    PubMed         Abstract available


    J Viral Hepat

  7. SQUIRES KE, Ogilvie L, Jucov A, Anastasiy I, et al
    A Randomized Phase 1b Trial of the Active Site Polymerase Inhibitor Nucleotide ATI-2173 in Patients With Chronic Hepatitis B Virus Infection.
    J Viral Hepat. 2022 Oct 6. doi: 10.1111/jvh.13753.
    PubMed         Abstract available

  8. HALL EW, Gounder P, Angles J, Nelson NP, et al
    Evaluating the Cost-Effectiveness of Hepatitis B Vaccination Strategies in High-impact Settings for Adults.
    J Viral Hepat. 2022 Oct 6. doi: 10.1111/jvh.13759.
    PubMed         Abstract available

  9. HEO M, Pericot-Valverde I, Niu J, Norton BL, et al
    More intensive hepatitis C virus care models promote adherence among people who inject drugs with active drug use: The PREVAIL Study.
    J Viral Hepat. 2022 Oct 5. doi: 10.1111/jvh.13756.
    PubMed         Abstract available

  10. MENDIZABAL M, Thompson M, Gonzalez-Ballerga E, Anders M, et al
    Implementation of a re-linkage to care strategy in patients with chronic hepatitis C who were lost to follow-up in Latin America.
    J Viral Hepat. 2022 Oct 5. doi: 10.1111/jvh.13758.
    PubMed         Abstract available

  11. BRYCE K, Smith C, Rodger A, Macdonald D, et al
    Falling treatment uptake in the hepatitis C care cascade is a growing threat to achieving elimination.
    J Viral Hepat. 2022 Oct 5. doi: 10.1111/jvh.13757.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Hepatitis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: